Halmstad University Report issue

Academic/Hospital Phase 2 Phase 4
Founded: Halmstad Sweden (1983)

Organization Overview

First Clinical Trial
2007
NCT00613769
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2019

Timeline

NOW
  • Now

Alternative names

Department of Surgery and Oncology, Halland Hospital Halmstad, 301 85 Halmstad, Sweden | Halland County Council, Department of Dermatology and Infectious diseases, Halmstad, Sweden | Halland Hospital Halmstad | Halmstad County Hospital | Halmstad University

Active Ingredients

Drugs in Phase 4 Trials (4)

cefuroxime (zinacef) (1 trial)

metronidazole (flagyl) (1 trial)

sulfamethoxazole (gantanol) (1 trial)

trimethoprim (1 trial)

Drugs in Phase 2 Trials (1)

chronseal (1 trial)

Drugs in Other Trials (1)

lactobacillus reuteri (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Communicable Diseases (Phase 4)

Infections (Phase 4)

Leg Ulcer (Phase 2)

Ulcer (Phase 2)

Varicose Ulcer (Phase 2)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 3
  • # of Trial APIs: 6